Analysts Set Rapport Therapeutics, Inc. (NASDAQ:RAPP) Target Price at $51.40

Shares of Rapport Therapeutics, Inc. (NASDAQ: RAPP - Get Free Report) have been given an average recommendation of "Moderate Buy" by the nine brokerages that are currently covering the stock, MarketBeat reports. One equities research analyst has rated the stock with a sell recommendation, seven have assigned a buy recommendation and one has given a strong